Analyst Ratings for ISIS Pharmaceuticals (ISIS)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 4.4 / 10
Percentile Rank: 44%
Rating Score: 4.4 / 10
Percentile Rank: 44%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/4/2015 | Wells Fargo | N/A | New Coverage | Overweight (N/A) |
N/A (N/A) |
60.70 (57.56) |
-5.17% | Details |
| 11/18/2015 | Goldman Sachs | N/A | New Coverage | Neutral (N/A) |
65.00 (N/A) |
61.32 (57.56) |
-6.13% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
